1[1]Yoshida YK, Yoshimoto T, Shirane R, et al. Clinical course, surgical management, and long-term outcome of moyamoya patients witjh rebleeding after and episode of intracerebral hemorhhage. An extensive follow-up study. Stroke, 1999, 30:2272～2276
2[2]Peeress SJ. Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg, 1997,99(Suppl 2):S45～48
3[3]Chiu D, Shedden P, Bratina P, et al. Clinical features of moyamoya disease in the United States. Stroke, 1998, 29:1347～1351
4[4]Matsushima Y, Qian L, Aoyagi M. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome )in the People`s Republic of China. Clin Neurol Neurosurg. 1997,99(Suppl2):S19～22
5[5]Yamada H, Deguchi K, Tanigawara T, et al. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg, 1997, 99(Suppl1):S221～224
6[6]Yamauchi T, H oukin K, Tada M, et al. Familial occurrence of moyamoya disease. Clin Neurol Neurosurg, 1997, 99(Suppl2):S162～167
7[7]Fukui M. Current study on moyamoya disease in Japan. Surg Neurol, 1997, 47:138～143
8[8]Natori, Y, Ikezaki K, Matsushima T, et al. “Angiographic moyamoya” its dedinition, classification, and therapy. Clin Neurol Neurosurg, 1997,99(Suppl2):S168～172
9[9]Yoshida YK, Shirane R, Yoshimoto T, et al. Non-anastmotic bypass surgery for childhodd moyamoya disease using dural pedicle insertion over the brain surface combined with encephalogaleomyosynangiosis. Surg Neurol, 1999, 51:404～411
10[10]Iwama T, Morimoto M, Hashimoto N, et al. Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg, 1997, 99(Suppl2):S187～190
